title: Targeting a bacterial stress response to enhance antibiotic action.
abstract: This report describes the identification and analysis of a 2-component regulator of Pseudomonas aeruginosa that is a potential aminoglycoside antibiotic combination therapy target. The regulator, AmgRS, was identified in a screen of a comprehensive, defined transposon mutant library for functions whose inactivation increased tobramycin sensitivity. AmgRS mutations enhanced aminoglycoside action against bacteria grown planktonically and in antibiotic tolerant biofilms, against genetically resistant clinical isolates, and in lethal infections of mice. Drugs targeting AmgRS would thus be expected to enhance the clinical efficacy of aminoglycosides. Unexpectedly, the loss of AmgRS reduced virulence in the absence of antibiotics, indicating that its inactivation could protect against infection directly as well as by enhancing aminoglycoside action. Transcription profiling and phenotypic analysis suggested that AmgRS controls an adaptive response to membrane stress, which can be caused by aminoglycoside-induced translational misreading. These results help validate AmgRS as a potential antibiotic combination target for P. aeruginosa and indicate that fundamental stress responses may be a valuable general source of such targets.
authors.affiliation: Departments of Genome Sciences and Medicine and Microbiology, University of Washington, Seattle, WA 98195, USA.
authors.forename: Samuel
authors.initials: S
authors.lastname: Lee
authors.forename: Aaron
authors.initials: A
authors.lastname: Hinz
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Bauerle
authors.forename: Angus
authors.initials: A
authors.lastname: Angermeyer
authors.forename: Katy
authors.initials: K
authors.lastname: Juhaszova
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Kaneko
authors.forename: Pradeep K
authors.initials: PK
authors.lastname: Singh
authors.forename: Colin
authors.initials: C
authors.lastname: Manoil
mesh_terms: D000617:Aminoglycosides / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004251:DNA Transposable Elements / Q000235:genetics; D024881:Drug Resistance, Bacterial / Q000235:genetics; D015964:Gene Expression Regulation, Bacterial; D005798:Genes, Bacterial / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D008826:Microbial Sensitivity Tests; D016254:Mutagenesis, Insertional; D009154:Mutation; D011552:Pseudomonas Infections / Q000382:microbiology / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000235:genetics / Q000472:pathogenicity; D014031:Tobramycin / Q000494:pharmacology*; D014774:Virulence / Q000187:drug effects
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D004251:DNA Transposable Elements; D014031:Tobramycin
references.citation: Antimicrob Agents Chemother. 2004 Jul;48(7):2431-6
references.pmid: 15215091
references.citation: Proc Natl Acad Sci U S A. 2006 May 30;103(22):8487-92
references.pmid: 16687478
references.citation: Curr Opin Microbiol. 2006 Oct;9(5):445-53
references.pmid: 16942902
references.citation: J Bacteriol. 2009 Mar;191(6):1798-815
references.pmid: 19103922
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14339-44
references.pmid: 14617778
references.citation: Antimicrob Agents Chemother. 2005 Feb;49(2):479-87
references.pmid: 15673721
references.citation: J Bacteriol. 2008 Sep;190(17):5981-8
references.pmid: 18621901
references.citation: Antimicrob Agents Chemother. 2008 Dec;52(12):4213-9
references.pmid: 18824604
references.citation: Antimicrob Agents Chemother. 2008 Dec;52(12):4486-91
references.pmid: 18824609
references.citation: Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51
references.pmid: 14555458
references.citation: Annu Rev Microbiol. 2003;57:677-701
references.pmid: 14527295
references.citation: N Engl J Med. 2002 Oct 3;347(14):1110-1
references.pmid: 12362015
references.citation: Lancet Infect Dis. 2005 Feb;5(2):115-9
references.pmid: 15680781
references.citation: Cell. 2007 Sep 7;130(5):797-810
references.pmid: 17803904
references.citation: Nat Rev Drug Discov. 2007 Jan;6(1):41-55
references.pmid: 17159922
references.citation: BMJ. 2007 Nov 3;335(7626):929-32
references.pmid: 17974689
references.citation: J Bacteriol. 2002 Dec;184(23):6472-80
references.pmid: 12426334
references.citation: Nat Rev Drug Discov. 2007 Jan;6(1):29-40
references.pmid: 17159923
references.citation: J Clin Invest. 2007 Apr;117(4):877-88
references.pmid: 17364024
references.citation: Proc Natl Acad Sci U S A. 1990 Jul;87(13):4937-41
references.pmid: 2164211
references.citation: Adv Exp Med Biol. 2008;631:229-36
references.pmid: 18792693
references.citation: Biosci Biotechnol Biochem. 2006 Jul;70(7):1688-95
references.pmid: 16861804
references.citation: J Bacteriol. 1998 Feb;180(4):831-9
references.pmid: 9473036
references.citation: Curr Opin Microbiol. 2007 Oct;10(5):441-6
references.pmid: 17950658
references.citation: PLoS One. 2008 Feb 20;3(2):e1619
references.pmid: 18286176
references.citation: Biochim Biophys Acta. 2004 Nov 11;1694(1-3):121-34
references.pmid: 15546662
references.citation: J Biol Chem. 2002 Jul 19;277(29):26652-61
references.pmid: 11953442
references.citation: Antimicrob Agents Chemother. 2003 Jan;47(1):317-23
references.pmid: 12499208
references.citation: Genes Cells. 2002 Jul;7(7):653-62
references.pmid: 12081643
references.citation: Curr Opin Microbiol. 2005 Apr;8(2):122-6
references.pmid: 15802241
references.citation: Annu Rev Microbiol. 2005;59:211-31
references.pmid: 15910274
references.citation: Mol Microbiol. 2002 Oct;46(1):281-91
references.pmid: 12366850
references.citation: Drug Discov Today. 2005 Sep 15;10(18):1245-52
references.pmid: 16213417
references.citation: Mol Microbiol. 1997 Jan;23(2):345-54
references.pmid: 9044268
references.citation: Microbiol Rev. 1987 Sep;51(3):341-50
references.pmid: 3312985
references.citation: Cell. 2008 Nov 14;135(4):679-90
references.pmid: 19013277
references.citation: Proc Natl Acad Sci U S A. 1986 Aug;83(16):6164-8
references.pmid: 2426712
references.citation: Mol Microbiol. 2008 Dec;70(5):1076-93
references.pmid: 18710431
references.citation: J Mol Biol. 1998 May 29;279(1):175-88
references.pmid: 9636708
references.citation: Bioorg Med Chem. 2002 Apr;10(4):855-67
references.pmid: 11836091
references.citation: J Bacteriol. 2003 Aug;185(16):4956-72
references.pmid: 12897016
references.citation: Antimicrob Agents Chemother. 2000 Mar;44(3):658-64
references.pmid: 10681335
references.citation: Curr Opin Microbiol. 2008 Oct;11(5):387-92
references.pmid: 18804175
references.citation: Biochem Pharmacol. 2006 Mar 30;71(7):910-8
references.pmid: 16427026
references.citation: Biochem Pharmacol. 2006 Mar 30;71(7):901-9
references.pmid: 16494849
references.citation: Antimicrob Agents Chemother. 2007 Sep;51(9):3388-90
references.pmid: 17576840
references.citation: J Gen Microbiol. 1992 Mar;138(3):551-61
references.pmid: 1375623
references.citation: Chest. 2007 Aug;132(2):562-8
references.pmid: 17646236
references.citation: Gene. 1998 May 28;212(1):77-86
references.pmid: 9661666
references.citation: Trends Biotechnol. 2007 Dec;25(12):547-55
references.pmid: 17997179
references.citation: Res Microbiol. 2006 May;157(4):306-14
references.pmid: 16487683
references.citation: J Bacteriol. 2006 Mar;188(5):1847-55
references.pmid: 16484195